ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,440, issued on Dec. 30, was assigned to NovaOnco JS Therapeutics Co. Ltd. (Jiangsu Province, China).
"Fluorovinylbenzamide compound as PD-L1 immunomodulator" was invented by Yang Zhang (Shanghai), Yuanfeng Xia (Shanghai), Deheng Sun (Shanghai), Jian Zuo (Shanghai), Zhengxia Chen (Shanghai), Meibi Dai (Shanghai), Jian Li (Shanghai) and Shuhui Chen (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a PD-L1 immunomodulator, and specifically discloses a compound of formula (I) as a PD-L1 immunomodulator, a pharmaceutically acceptable salt or an isomer thereof."
The patent was filed on Feb. 3, 2020, under Applicati...